Ventac Capital

Ventac Capital is rated 3 out of 5 in the category venture capital & private equity. Read and write reviews about Ventac Capital. Ventac Capital is a pan-European life science investment fund, with a unique combination of investment and operational expertise. Ventac Capital has a proven investment team with extensive executive and board experience in building, running and successfully transacting early and mid-stage companies to create shareholder value. Investment Approach: Our experience positions us to understand entrepreneurs, the business opportunity and drives our active role in creating value within our portfolio companies. With each individual investment, we carefully define business strategy with an eye to an exit; we build the business plan with entrepreneurs and actively manage execution, integrating with the company as an extension of the operating team. Our investment focus is on patient-centric innovations within life sciences. In particular, we look for proprietary, differentiated therapeutic products addressing high-unmet medical need and platform technologies supporting next-generation patient diagnosis, treatment and disease prevention. We source opportunities globally, primarily from industry, start-up communities and business accelerators. Our hands-on approach shapes each investment opportunity towards its business potential with a 3-5 year runway to strategic partnerships, acquisition by large life science companies or an IPO. Ventac Capital has a deep global network for sourcing, deal making and talent acquisition, inclusive of Ventac Partners, see www.ventac-partners.com , and other international experts. We strive to maximize shareholder returns for all portfolio companies with our capital efficient model and shorter time to realization.